Your search matched 48 results
The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
Big Pharma Fund Fights Menacing Superbugs | Blog
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.
Fors Marsh Group Selected by HHS to Build $250 Million Public Coronavirus Campaign | Blog
The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
Best Practices: Social Media Content and Activity During COVID-19 | Perspectives
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
COVID-19: How are Payers Managing These Days? | Perspectives
How are payers responding to COVID-19?
Contingency 2020: Four Strategic Ways to Maintain Momentum Through Disruption | Perspectives
Four Rapid Response Approaches To Maintain Business Momentum
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
Israel Gets Head Start in Race for COVID-19 Vaccine | Blog
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives
Virtual delivery requires you to rethink your content and approaches.
PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
Here are a Few Changes We Can Expect to See in Our World After COVID | Blog
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
P2P Networks Huge for COVID-19 Patients, Responders | Blog
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog
Patients are often at risk when presented with mixed messages.
Looking Beyond COVID-19, Walgreens to Open Clinics in Underserved Communities | Blog
Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.
Novo Nordisk Tailors Launch for COVID-era Customers | Blog
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
COVID’s Consequences Clearer as Cancer Cases Climb | Blog
At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.
2020 Employee Communications and Behavioral Science Contingency | Perspectives
Recommendations for activities to inform and engage
What to Expect From Contact Tracing in Our Next Phase of COVID-19 | Blog
You might want to think twice about ignoring that call from a random number.
Our Virtual Reality | Perspectives
Virtual collaboration isn’t the future of work – it's the wave of the present
The Syneos Health Podcast, Coronavirus Special Edition: Telemedicine in the Age of COVID-19 | Perspectives
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Four Critical Dynamics for Virtual Collaboration | Blog
Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.
Pivot Past the Pandemic | Perspectives
Life sciences commercialization in the COVID-19 era and beyond
Already have a RSS feed reader?
